'These distinct roles for EZH2 in promoting prostate cancer progression, metastasis, and AR independence raise the possibility that it could be a potential therapeutic target in advanced disease.'

https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002038